NEAT1 and hepatocellular carcinoma: In contrast, neither rapamycin nor NEAT1_2 significantly affected HCC growth under low glucose conditions, albeit the overall growth rate was also lower due to limited nutrition (right panel, Figure 7F), suggesting that mTORC1-NEAT1 axis promotes rapamycin-sensitive cancer cell growth through glucose metabolism.